Poverty and survival in targeted immunotherapy clinical trials.

被引：1
|
作者：
Bona, Kira O'Neil
Li, Yimei
Winestone, Lena
Getz, Kelly D.
Huang, Yuan-Shung
Fisher, Brian
Desai, Ami Vijay
Richardson, Troy
Hall, Matt
Naranjo, Arlene
Henderson, Tara O.
Aplenc, Richard
Bagatell, Rochelle
机构：
[1] Childrens Hosp Boston, Dana Farber Canc Inst, Boston, MA USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[3] UCSF Benioff Childrens Hosp, San Francisco, CA USA
[4] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[5] Univ Chicago, Med Ctr, Comer Childrens Hosp, Chicago, IL 60637 USA
[6] Childrens Hosp Assoc, Shawnee Mission, KS USA
[7] Childrens Hosp Assoc, Overland Pk, KS USA
[8] Univ Florida, Childrens Oncol Grp, Stat & Data Ctr, Gainesville, FL USA
[9] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.10034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10034
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma
    Bona, Kira
    Li, Yimei
    Winestone, Lena E.
    Getz, Kelly D.
    Huang, Yuan-Shung
    Fisher, Brian T.
    Desai, Ami, V
    Richardson, Troy
    Hall, Matt
    Naranjo, Arlene
    Henderson, Tara O.
    Aplenc, Richard
    Bagatell, Rochelle
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (03) : 282 - 291
  • [2] Clinical Trials 102: New Strategies in Targeted Therapy Clinical Trials.
    Hilsenbeck, S. G.
    Piccart, M.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 483S - 483S
  • [3] Highlighting the challenge of delayed overall survival (OS) curve separation in immunotherapy clinical trials.
    Steele, Savanna D.
    Wang, Song
    Solinger, Alan
    Combest, Austin J.
    Bonneterre, Marie-Edith Anne
    Reitsma, Dirk J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials.
    Unger, Joseph M.
    Vaidya, Riha
    Albain, Kathy S.
    LeBlanc, Michael Leo
    Minasian, Lori M.
    Gotay, Carolyn
    Henry, Norah Lynn
    Fisch, Michael Jordan
    Ramsey, Scott David
    Blanke, Charles David
    Lyman, Gary H.
    Hershman, Dawn L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Survival analysis - An alternative approach to applying data in clinical trials.
    Hannigan, A
    [J]. JOURNAL OF DENTAL RESEARCH, 1996, 75 (05) : 1242 - 1242
  • [6] NGS panels' capture of biomarkers associated with targeted therapies in clinical trials.
    Fox, John Leonard
    Daniel, Sugganth
    Abrol, Manavi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Ancient clinical trials.
    Lewis, EJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01): : 83 - 84
  • [8] Glycitein for clinical trials.
    Verbruggen, MA
    Olieman, K
    [J]. JOURNAL OF NUTRITION, 2002, 132 (03): : 601S - 601S
  • [9] Exclusion rates of patients living with HIV from cancer immunotherapy clinical trials.
    Vora, Kruti Bhagirath
    Awad, Mark M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Survival of patients with gastrointestinal malignancies participating in phase 1 clinical trials.
    Denson, Aaron Cleveland
    Burke, Nancy
    Bertels, Barbara
    Wapinsky, Georgine
    Juan, TzuHua
    Lee, Jae K.
    Sullivan, Daniel
    Mahipal, Amit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345